Current guidelines for the delay and prevention of type 2 diabetes mellitus recommend for people with prediabetes to lose at least 7% of their body weight. Here, we advocate to use glycaemic remission as a goal of prevention in people with prediabetes and those who are at high risk for type 2 diabetes mellitus.
This is a preview of subscription content, log in via an institution to check access.
References
Nathan, D. M. et al. Does diabetes prevention translate into reduced long-term vascular complications of diabetes? Diabetologia 62, 1319–1328 (2019).
American Diabetes Association Professional Practice Committee. prevention or delay of diabetes and associated comorbidities: standards of care in diabetes-2024. Diabetes Care 47 (Suppl 1), S43–S51 (2024).
Sandforth, A. et al. Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS). Lancet Diabetes Endocrinol. 11, 798–810 (2023).
Fritsche, A. et al. Different effects of lifestyle intervention in high- and low-risk prediabetes: results of the randomized controlled Prediabetes Lifestyle Intervention Study (PLIS). Diabetes 70, 2785–2795 (2021).
Zhyzhneuskaya, S. V. et al. Time course of normalization of functional β-cell capacity in the diabetes remission clinical trial after weight loss in type 2 diabetes. Diabetes Care 43, 813–820 (2020).
Tabák, A. G. et al. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373, 2215–2221 (2009).
Jumpertz von Schwartzenberg, R., Vazquez Arreola, E., Sandforth, A. et al. Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention. Diabetologia https://doi.org/10.1007/s00125-024-06178-5 (2024).
Taylor, R. Type 2 diabetes and remission: practical management guided by pathophysiology. J. Intern. Med. 289, 754–770 (2021).
Sathish, T. et al. Effect of conventional lifestyle interventions on type 2 diabetes incidence by glucose-defined prediabetes phenotype: an individual participant data meta-analysis of randomized controlled trials. Diabetes Care 46, 1903–1907 (2023).
Wagner, R. et al. Pathophysiology-based subphenoty** of individuals at elevated risk for type 2 diabetes. Nat. Med. 27, 49–57 (2021).
Acknowledgements
The authors acknowledge the members of ‘The Prediabetes Group’, who are listed in the Supplementary Information document, for their assistance with reviewing this article. A.L.B. acknowledges the support of funding from the German Federal Ministry for Education and Research (01GI0925) via the German Center for Diabetes Research (DZD e.V.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Related links
Diabetes mellitus: https://www.who.int/news-room/fact-sheets/detail/diabetes
World Health Organization’s global targets for noncommunicable diseases: https://www.who.int/publications/i/item/9789241506236
Supplementary information
Rights and permissions
About this article
Cite this article
Birkenfeld, A.L., Mohan, V. Prediabetes remission for type 2 diabetes mellitus prevention. Nat Rev Endocrinol (2024). https://doi.org/10.1038/s41574-024-00996-8
Published:
DOI: https://doi.org/10.1038/s41574-024-00996-8
- Springer Nature Limited